Literature DB >> 209061

Bone marrow-derived lymphoid cell lines from patients with agammaglobulinemia.

J Schwaber, H Lazarus, F S Rosen.   

Abstract

In vitro infection with Epstein-Barr virus of bone marrow-derived (B) lymphocytes from blood of patients with X-linked or common varied agammaglobulinemia resulted in the establishment of long-term B-lymphoid cell lines (LCL). LCL were established only with B lymphocytes from patients whose B cells failed to respond to in vitro mitogenic stimulation. In contrast, lymphocytes from patients without small B lymphocytes or with B cells that synthesized but failed to secrete Ig failed uniformly to establish LCL. Analysis of the "nonsecretory" B lymphocytes demonstrated the presence of receptors for C3b and C3d as well as surface Ig, but absence of detectable receptors for Epstein-Barr virus. All of the six cell lines that were established formed rosettes with EAC3 but not with sheep erythrocytes. Four of the six LCL were principally surface IgD bearing and did not synthesize detectable Ig for secretion. Two of the cell lines were indistinguishable from cell lines from normal individuals: they had surface IgG, A, M, and D and synthesized and secreted Ig.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 209061      PMCID: PMC371767          DOI: 10.1172/JCI109130

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  CONTINUOUS CULTURE OF HUMAN LYMPHOBLASTS FROM PERIPHERAL BLOOD OF A CHILD WITH ACUTE LEUKEMIA.

Authors:  G E FOLEY; H LAZARUS; S FARBER; B G UZMAN; B A BOONE; R E MCCARTHY
Journal:  Cancer       Date:  1965-04       Impact factor: 6.860

2.  Assay for the two different types of lymphocyte complement receptors.

Authors:  G D Ross; M J Polley
Journal:  Scand J Immunol       Date:  1976-06       Impact factor: 3.487

3.  Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro.

Authors:  A Rosén; P Gergely; M Jondal; G Klein; S Britton
Journal:  Nature       Date:  1977-05-05       Impact factor: 49.962

4.  Isolation on discontinuous gradients of bovine albumin of a subpopulation of human lymphocytes exhibiting precursor characteristics.

Authors:  J G Gatien; E E Schneeberger; R Parkman; E Merler
Journal:  Eur J Immunol       Date:  1975-05       Impact factor: 5.532

5.  Quantitative measurements of T- and B-cell function in "variable" primary hypogammaglobulinaemia: evidence for a consistent B-cell defect.

Authors:  E G de la Concha; G Oldham; A D Webster; G L Asherson; T A Platts-Mills
Journal:  Clin Exp Immunol       Date:  1977-02       Impact factor: 4.330

6.  IgD on cell membranes of human lymphoid cell lines with multiple immunoglobulin classes.

Authors:  J A van Boxel; D N Buell
Journal:  Nature       Date:  1974-10-04       Impact factor: 49.962

7.  High-frequency establishment of human immunoglobulin-producing lymphoblastoid lines from normal and malignant lymphoid tissue and peripheral blood.

Authors:  K Nilsson
Journal:  Int J Cancer       Date:  1971-11-15       Impact factor: 7.396

8.  Abnormalities in the glycosylation of immunoglobulin heavy chain and an h-2 transplantation antigen in a mouse myeloma mutant.

Authors:  S Weitzman; S G Nathenson; M D Scharff
Journal:  Cell       Date:  1977-04       Impact factor: 41.582

9.  Interaction of human thymus-derived and non-thymus-derived lymphocytes in vitro. Induction of proliferation and antibody synthesis in B lymphocytes by a soluble factor released from antigen-stimulated T lymphocytes.

Authors:  R S Geha; E Schneeberger; F S Rosen; E Merler
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

10.  Epstein-barr virus-negative human malignant T-cell lines.

Authors:  J Kaplan; T C Shope; W D Peterson
Journal:  J Exp Med       Date:  1974-05-01       Impact factor: 14.307

View more
  10 in total

1.  Interleukin-4 suppresses immunoglobulin production by peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) induced by supernatants of T cell clones.

Authors:  G Pastorelli; M G Roncarolo; J L Touraine; F Rousset; J Pene; J E de Vries
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

2.  The capacity of interleukin-4 to induce in vitro IgE synthesis by B cells of patients with common variable immunodeficiency.

Authors:  G Pastorelli; M G Roncarolo; C Peronne; P A Tovo; J E de Vries
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

3.  B lymphocytes from X-linked agammaglobulinemia. Delayed expression of light chain and demonstration of Lyonization in carriers.

Authors:  J Schwaber; J Payne; R Chen
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

4.  Epstein-Barr virus-induced immunoglobulin synthesis by B cells from individuals with late-onset panhypogammaglobulinemia.

Authors:  P L Haber; H Kubagawa; M D Cooper
Journal:  J Clin Immunol       Date:  1983-07       Impact factor: 8.317

5.  Epstein-Barr virus-induced lymphoblastoid cell lines derived from the peripheral blood of patients with X-linked agammaglobulinemia can secrete IgM.

Authors:  D Levitt; H Ochs; R J Wedgwood
Journal:  J Clin Immunol       Date:  1984-03       Impact factor: 8.317

6.  Isotypes of surface immunoglobulin on B lymphocytes from patients with immune deficiency.

Authors:  J F Schwaber; F S Rosen
Journal:  J Clin Immunol       Date:  1982-01       Impact factor: 8.317

7.  Reactivity of a monoclonal antibody with human ovarian carcinoma.

Authors:  R C Bast; M Feeney; H Lazarus; L M Nadler; R B Colvin; R C Knapp
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

8.  Functional 'immaturity' of isolated B cells from patients with hypogammaglobulinaemia.

Authors:  G C De Gast; S R Wilkins; A D Webster; A Rickinson; T A Platts-Mills
Journal:  Clin Exp Immunol       Date:  1980-12       Impact factor: 4.330

9.  Induction of human immunoglobulin synthesis and secretion in somatic cell hybrids of mouse myeloma and human B lymphocytes from patients with agammaglobulinemia.

Authors:  J F Schwaber; F S Rosen
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

10.  Pre-B cells and other possible precursor lymphoid cell lines derived from patients with X-linked agammaglobulinemia.

Authors:  S M Fu; J N Hurley; J M McCune; H G Kunkel; R A Good
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.